Valuation : Adocia

Market Cap 76.93M 89.48M 72.38M 66.05M 123M 8.48B 124M 858M 332M 4.34B 336M 329M 13.8B P/E 2026 *
-718x
P/E 2027 * 5.69x
Enterprise Value 47.09M 54.77M 44.3M 40.43M 75.45M 5.19B 75.84M 525M 203M 2.65B 206M 201M 8.45B EV / Sales 2026 *
18.7x
EV / Sales 2027 * 3.03x
Free-Float
96.05%
Yield 2026 *
-
Yield 2027 * -
1 day+0.25%
1 week-4.41%
Current month-1.15%
1 month-3.57%
3 months-2.52%
6 months-36.83%
Current year-41.16%
1 week 3.88
Extreme 3.88
4.13
1 month 3.88
Extreme 3.88
4.3
Current year 3.61
Extreme 3.61
7.45
1 year 3.61
Extreme 3.61
12.4
3 years 2.86
Extreme 2.86
12.66
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
61.9
Manager TitleAgeSince
Chief Executive Officer 55 2023-05-10
Director of Finance/CFO - 2024-09-22
Chief Tech/Sci/R&D Officer - 2014-11-30
Director TitleAgeSince
Director/Board Member 55 2013-04-18
Chairman 57 -
Director/Board Member 61 2023-05-10
Date Insider Type Main position Quantity % Market Cap. Importance
2/27/25 Buy

Founder

109,170 0.6972%
4/6/24 Buy

Founder

15,576 0.1105%
4/6/24 Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
+0.36%-4.41%-51.03%-60.22% 89.48M
+2.02%+1.26%+41.37%+105.18% 69.19B
-0.83%-4.62%+31.59%+74.70% 62.97B
-1.11%+2.78%-14.86%+375.59% 27.27B
-4.92%-3.22%-3.90%-17.87% 24.78B
-1.22%-1.10%+29.31%+14.05% 25.8B
+0.32%-0.09%+23.54%-16.17% 20.11B
+6.04%+7.25%+233.25%+383.12% 18.47B
-1.23%-2.27%-7.97%+516.90% 14.88B
-2.27%+1.37%+53.01%+160.83% 14.29B
Average -0.29%+0.45%+33.43%+153.61% 27.79B
Weighted average by Cap. -0.09%+0.11%+37.87%+139.92%

Financials

2026 *2027 *
Net sales 2.52M 2.93M 2.37M 2.16M 4.04M 278M 4.06M 28.11M 10.87M 142M 11.01M 10.77M 452M 35.4M 41.17M 33.3M 30.39M 56.72M 3.9B 57.01M 395M 153M 2B 155M 151M 6.35B
Net income -4.32M -5.02M -4.06M -3.71M -6.92M -476M -6.95M -48.12M -18.62M -243M -18.85M -18.44M -774M -44.33M -51.56M -41.7M -38.06M -71.02M -4.89B -71.39M -494M -191M -2.5B -194M -189M -7.95B
Net Debt -29.84M -34.71M -28.08M -25.62M -47.82M -3.29B -48.06M -333M -129M -1.68B -130M -127M -5.35B 30.18M 35.1M 28.39M 25.91M 48.35M 3.33B 48.6M 336M 130M 1.7B 132M 129M 5.41B
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
73
Date Price Change Volume
26-09-09 3.946 +0.36% 5,579
26-09-08 €3.932 -0.61% 80,528
26-09-07 €3.956 -1.10% 51,512
26-09-04 €4.000 -3.10% 37,883
26-09-03 €4.128 +0.10% 71,464
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.932EUR
Average target price
9.700EUR
Spread / Average Target
+146.69%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADOC Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!